PharmaShots | Incisive News in 3 Shots

Subscribe Now

Refuses

BMS and bluebird bio to Resubmit the BLA for Idecabtagene Vicleucel (ide-cel- bb2121) to Treat Patients with Multiple Myeloma

BMS and bluebird bio to Resubmit the BLA for Idecabtagene Vicleucel (ide-cel- bb2121) to Treat Patients with Multiple Myeloma

May 14, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us